Hóa trị được thực hiện kết hợp với việc sửa đổi rào chắn máu-não bằng phương pháp thẩm thấu trong bệnh nhân có di căn não

Greig, NH: Chemotherapy of brain metastases: Current status. Cancer Treat Rev 11:157–186, 1984. Neuwelt, EA, Frenkel, EP: Is there a therapeutic role for blood-brain barrier disruption? Ann Int Med 93:137–139, 1980. Logothetis, CJ, Samuels, ML, Trindade, A: The management of brain metastases in germ cell tumors. Cancer 49:12–18, 1982. Espana, P, Chang, P, Wiernick, PH: Increased incidence of brain metastases in sarcoma patients. Cancer 45:377–380, 1980. Posner, J: Diagnosis and treatment of metastases to the brain. Clin Bull 4:47–57, 1974. Posner, J: Management of central nervous system metastases. Semin Oncol 4:81–91, 1977. Posner, J: Brain metastasis: A clinician's view. In: Weiss, L, Gilbert, H, Posner, J (eds) Brain Metastasis. Martinus Nijhoff, The Hague, 1980. Gercovich, R, Launa, M, Gottleib, J: Increased incidence of cerebral metastasis in sarcoma patients with prolonged survival from chemotherapy. Report of cases of leiomyosarcoma and chondrosarcoma. Cancer 36:1843–1851, 1975. Mayer, R, Berkowitz, R, Griffiths, C: Central nervous system involvement by ovarian carcinoma. Cancer 41:776–783, 1978. Vick, NA, Khandekar, JD, Bigner, DD: Chemotherapy of brain tumors: The ‘blood-brain barrier’ is not a factor. Arch Neurol 34:523–526, 1977. Rosner, D, Nemoto, T, Pickren, J, Lane, W: Management of brain metastases from breast cancer by combination chemotherapy. J Neuro-Oncology 1:131–137, 1983. Hasegawa, H, Ushio, Y, Hayakawa, T, Yamada, K, Mogami H: Changes of the blood-brain barrier in experimental metastatic brain tumors. J Neurosurg 59:304–310, 1983. Groothuis DR, Molnar P, Blasberg RG: Regional blood flow and blood-to-tissue transport in five brain tumor models. In: Rosenblum M, Wilson CB (eds) Brain Tumor Biology. Prog exp Tumor Res 27:132–153, 1984. Levin, VA, Clancy, TP, Austrian, JI, Rall, DP: Uptake and distribution of 3H-methotrexate by the routine ependymoblastoma. J Natl Cancer Inst 488:875–883, 1972. Neuwelt, EA, Barnett, PA, Bigner, DD, Frenkel, EP: Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: The factor of the blood-brain barrier. Proc Natl Acad Sci 79:4420–4422, 1982. Walker, MD, Weiss, H: Chemotherapy in the treatment of malignant brain tumors. Adv Neurol 13:149–191, 1975. Frei, E, Canellos, GP: Dose: A critical factor in cancer chemotherapy. AJN 69:585–593, 1980. Benjamin, RS, Wiernik, PH, Bachiur, NR: Adriamycin chemotherapy — Efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer 33:19–27, 1974. Peng, G, Marquex, V, Driscoll, J: Potential central nervous system antitumor agents: Spirohydantoin mustard. J Med Chem 18:846–849, 1975. Sigman, L, Van Echo, D, Egorin, M, Reck, K, Kaplan, R, Salcman, M, Aisner, J: Phase I trial of spiromustine (NSC 172 112). Proc Am Soc Clin Oncol 3:31, 1974. Bodor, N, Roller, R, Selk, S: Elimination of a quaternary pyridinium salt delivered as its dihydropyridine derivative from the brain of mice. J Pharmacol Sci 67:685–687, 1978. Bodor, N, Shek, E, Higuchi, T: Delivery of a quaternary pyridinium salt across the blood-brain barrier as its dihydropyridine derivative. Science 190:155–156, 1975. Schouwenburg, PF, Van Putten, LM, Snow, GB: External carotid artery infusion with single- and multiple-drug regimens in the rat. Cancer 45:2259–2264, 1980. Broman, T, Olsson, O: Experimental study of contrast media for cerebral angiography with reference to possible injurious effects on the cerebral blood vessles. Acta Radiol 31:321–334, 1949. Hasegwa, H, Allen, JE, Mehta, BM, Shapiro, WR, Posner JB: Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis. Neurology 29:1280–1286, 1979. Neuwelt, EA, Frenkel, EP, Rapoport, S, Barnett, P: Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. Neurosurgery 7:36–43, 1980. Neuwelt, EA, Glasberg, M, Diehl, J, Frenkel, EP, Barnett, P: Osmotic blood-brain barrier disruption in posterior fossa of the dog. J Neurosurg 55:742–748, 1981. Neuwelt, EA, Maravilla, KR, Frenkel, EP, Barnett, P, Hill, S, Moore, RJ: Use of enhanced computerized tomography to evaluate osmotic blood-brain barrier disruption. Neurosurgery 6:49–56, 1980. Neuwelt, EA, Maravilla, KR, Frenkel, EP, Rapoport, SI, Hill SA, Barnett, PA: Osmotic blood-brain barrier disruption: Computerized tomography monitoring of chemotherapeutic agent delivery. J Clin Invest 64:684–688, 1979. Neuwelt, EA, Pagel, M, Barnett, P, Glasberg, M, Frenkel, EP: Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification. Cancer Res 41:4466–4470, 1981. Ohno, K, Frederieks, WK, Rapoport, SI: Osmotic opening of the blood-brain barrier to methotrexate in the rat. Neurology 12:323–328, 1979. Rapoport, SI: Blood-Brain Barrier in Physiology and Medicine. Raven Press, New York, 1976. Rapoport, SI, Frederieks, WR, Ohno, K, Pettigrew, KD: Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol 235:421–431, 1980. Neuwelt, EA, Barnett, PA, Frenkel, EP: Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus induced brain tumors in rodent: Observations on problems of drug delivery. Neurosurgery 14:154–160, 1984. Neuwelt, EA, Frenkel, E, D'Agostino, AN, Carney, D, Minna J, Barnett, P: Growth of human lung tumor in the brain of the nude rat as a new model to evaluate anti-tumor agent delivery across the blood-brain barrier. Cancer Res 45:2827–2833, 1985. Neuwelt, EA, Balaban, E, Diehl, J, Hill, S, Frenkel, E: Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. Neurosurgery 12:662–671, 1983. Neuwelt, EA, Diehl, JT, Long, H, Vu, LH, Hill, SA, Michael AJ, Frenkel, EP: Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. Ann Int Med 94:449–454, 1981. Neuwelt, EA, Frenkel, EP, Diehl, J, Vu, LH, Rapoport, S, Hill, S: Reversible osmotic blood-brain barrier disruption in humans: Implications for the chemotherapy of malignant brain tumors. Neurosurgery 7:44–52, 1980. Neuwelt, EA, Frenkel, EP, Gumerlock, MK, Braziel, R, Hill SA: Developments in the diagnosis and treatment of primary CNS lymphoma. Cancer 58:1609–1620, 1986. Neuwelt, EA, Hill, SA, Frenkel, EP: Osmotic blood-brain barrier modification and combination chemotherapy: Concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurgery 15:362–366, 1984. Neuwelt, EA, Specht, HD, Howieson, J, Haines, JE, Bennett MJ, Hill, SA, Frenkel, EP: Osmotic blood-brain barrier modification: Clinical documentation by enhanced CT scanning and/or radionuclide brain scanning. Am J Neuroradiol, 4:907–913, 1983; and Am J Radiol, 141:829–836, 1983. Neuwelt, EA, Howieson, J, Frenkel, EP, Specht, D, Weigel, R, Buchan, G, Colin, G, Hill, SA: Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. (Neurosurgery) 19:573–582, 1986. Neuwelt, EA, Specht, HD, Hill, SA: Permeability of human brain tumor to 99mTc-glucoheptonate and 99mTc-albumin: implications for monoclonal antibody therapy. J Neurosurg 65:194–198, 1986. Jellinger, K: Pathologic effects of chemotherapy. In: Walker MD (ed) Oncology of the Nervous System. Martinus Nijhoff Publishers, Boston, 1983, pp 285–340. Allen, JC: Childhood brain tumors: Current status of clinical trials in newly diagnosed and recurrent disease. Ped Clin North Am 32:633–651, 1985. Bleyer, WA: Neurologic sequelae of methotrexate and ionizing radiation: A new classification. Cancer Treat Rep 65:89–98, 1981. Peylan-Ramu, N, Poplack, NG, Pizzo, PA, Adornato, BT, De Chiro, G: Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. New Engl J Med 298:815–818, 1978. Price, RA, Jamieson, PA: The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 35:306–318, 1975. Rubinstein, LJ, Herman, MM, Long, TF, Wilbur, JR: Disseminated necrotizing leukoencephalopathy: A complication of treated central nervous system leukemia and lymphoma. Cancer 35:291–305, 1975. Schiffer, D, Giordana, MT, Soffietti, R, Sciolla, R: Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy. Acta Neuropathol 58:291–299, 1982. Neuwelt, EA, Barnett, P, McCormick, C, Frenkel, E, Minna JD: Osmotic blood-brain barrier modification: Monoclonal antibody, albumin and methotrexate delivery to CSF and brain. Neurosurgery 17:419–423, 1985.